Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;26(2):288-297.
doi: 10.1016/j.euroneuro.2015.12.010. Epub 2015 Dec 11.

Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats

Affiliations

Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats

Blake A Hutsell et al. Eur Neuropsychopharmacol. 2016 Feb.

Abstract

Cathinone and many of its analogs produce behavioral effects by promoting transporter-mediated release of the monoamine neurotransmitters dopamine, norepinephrine and/or serotonin. Stereoselectivity is one determinant of neurochemical and behavioral effects of cathinone analogs. This study compared effectiveness of the S(-) and R(+) enantiomers of cathinone and 4-methylcathinone to produce in vitro monoamine release and in vivo abuse-related behavioral effects in rats. For neurochemical studies, drug effects were evaluated on monoamine release through dopamine, norepinephrine, and serotonin transporters (DAT, NET and SERT, respectively) in rat brain synaptosomes. For behavioral studies, drug effects were evaluated on responding for electrical brain stimulation in an intracranial self-stimulation (ICSS) procedure. The cathinone enantiomers differed in potency [S(-)>R(+)], but both enantiomers were >50-fold selective at promoting monoamine release through DAT vs. SERT, and both enantiomers produced ICSS facilitation. The 4-methylcathinone enantiomers also differed in potency [S(-)>R(+)]; however, in neurochemical studies, the decrease in potency from S(-) to R(+)4-methylcathinone was less for DAT than for SERT, and as a result, DAT vs. SERT selectivity was greater for R(+) than for S(-)4-methylcathinone (4.1- vs. 1.2-fold). Moreover, in behavioral studies, S(-)4-methylcathinone produced only ICSS depression, whereas R(+)4-methylcathinone produced ICSS facilitation. This study provides further evidence for stereoselectivity in neurochemical and behavioral actions of cathinone analogs. More importantly, stereoselective 4-methylcathinone effects on ICSS illustrate the potential for diametrically opposite effects of enantiomers in a preclinical behavioral assay of abuse potential.

Keywords: 4-Methylcathinone; Cathinone; Drug abuse; Intracranial self-stimulation; Rat; Stereoselectivity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Chemical structures of S(−) and R(+) enantiomers of cathinone and 4-methylcathinone tested in this study.
Figure 2
Figure 2
Effects of (a, b) cathinone and (c, d) 4-methylcathinone enantiomers on monoamine release via DAT, SERT, and NET in rat brain tissue. Abscissae: drug concentration in M. Ordinates: percent maximal monoamine release. Each point shows mean±SD for n=3 experiments performed in triplicate. EC50 values derived from the concentration–effect curves are shown in Table 1.
Figure 3
Figure 3
Effects of cathinone enantiomers on ICSS. (a, b) Abscissae: frequency of electrical brain stimulation in log Hz. Ordinates: rate of ICSS maintained by each frequency of brain stimulation, expressed as percent maximum control rate (%MCR). (c, d) Abscissae: drug dose in mg/kg. Ordinates: rate of ICSS maintained across all brain stimulation frequencies, expressed as percent baseline number of stimulations per component. Filled points in (a) and (b) represent frequencies at which ICSS rates were statistically different from vehicle rates (P<0.05). In (c) and (d) * indicate significant increases and # indicated significant decreases in ICSS rates relative to vehicle for at least one stimulation frequency as determined by analysis of frequency–rate curves in panels (a) and (b). All data show mean±SEM for n=6 rats.
Figure 4
Figure 4
Effects of 4-methylcathinone enantiomers on ICSS. (a, b) Abscissae: frequency of electrical brain stimulation in log Hz. Ordinates: rate of ICSS maintained by each frequency of brain stimulation, expressed as percent maximum control rate (%MCR). (c, d) Abscissae: drug dose in mg/kg. Ordinates: rate of ICSS maintained across all brain stimulation frequencies, expressed as percent baseline number of stimulations per component. Filled points in (a) and (b) represent frequencies at which ICSS rates were statistically different from vehicle rates (P<0.05). In (c) and (d) * indicate significant increases and # indicated significant decreases in ICSS rates relative to vehicle for at least one stimulation frequency as determined by analysis of frequency–rate curves in panels (a) and (b). All data show mean±SEM for n=6 rats.

References

    1. Aarde SM, Angrish D, Barlow DJ, Wright MJ, Jr, Vandewater SA, Creehan KM, Taffe MA. Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol. 2013;18:786–799. - PMC - PubMed
    1. Balster RL, Schuster CR. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav. 1973;20:119–129. - PMC - PubMed
    1. Bauer CT, Banks ML, Blough BE, Negus SS. Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol. 2013;168:850–862. - PMC - PubMed
    1. Baumann MH, Ayestas MA, Partilla JS, Sink JR, Shulgin AT, Daley PF, Cozzi NV. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology. 2012;37:1192–1203. - PMC - PubMed
    1. Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive “bath salts” products. Neuropsychopharmacology. 2013;38:552–562. - PMC - PubMed

Publication types

MeSH terms

Substances